Drew Weissman

<p>Drew Weissman (born September 7, 1959) is an American physician and <a href="/facts/Immunologist/vylm0L8e">immunologist</a>  known for his contributions to <a href="/facts/RNA/HxPeNfNj">RNA</a> biology.
Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the <a href="/facts/Perelman_School_of_Medicine_at_the_University_of_Pennsylvania/B6kHMHk7">Perelman School of Medicine at the University of Pennsylvania</a> (Penn).
</p><p>Weissman's work underlies the development of <a href="/facts/MRNA_vaccine/PCUBVuSw">mRNA vaccines</a>, the best known of which are <a href="/facts/COVID-19_vaccine/obToxWTT">those for COVID-19</a> produced by <a href="/facts/BioNTech/8f9h6cwq">BioNTech</a>/<a href="/facts/Pfizer/1ADDanWs">Pfizer</a> and <a href="/facts/Moderna/tjjjJqNs">Moderna</a>. With <a href="/facts/Biochemist/gAWNAY5v">biochemist</a> <a href="/facts/Katalin_Karik%C3%B3/6d4f0643">Katalin Karikó</a>, Weissman received the <a href="/facts/2023_Nobel_Prize_in_Physiology_or_Medicine/EIWsNS3b">Nobel Prize in Physiology or Medicine in 2023</a> "for their discoveries concerning <a href="/facts/Nucleoside/G40crf0F">nucleoside</a> base modifications that enabled the development of effective mRNA vaccines against COVID-19". Weissman has been a recipient and co-recipient of numerous awards, also including the prestigious <a href="/facts/Lasker%E2%80%93DeBakey_Clinical_Medical_Research_Award/TAww4yd0">Lasker–DeBakey Clinical Medical Research Award</a>. In 2022, he was elected to the <a href="/facts/National_Academy_of_Medicine/FdIo0Nd4">National Academy of Medicine</a> and the <a href="/facts/American_Academy_of_Arts_and_Sciences/KptWYgz4">American Academy of Arts and Sciences</a>.
</p>

Drew Weissman open-in-new

Drew Weissman